VEGFA and neoplasm: Furthermore, activation of VPAC1 by VIP stimulates the expression of angiogenic VEGF, the pro-inflammatory enzyme COX-2, and the increased activity of MMP-2 and 9 in tumours derived from VIP-treated PC3 cells [109].